Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dahlbäck B[au]:

Search results

Items: 1 to 50 of 407

1.

New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short.

Dahlbäck B, Guo LJ, Zöller B, Tran S.

J Thromb Haemost. 2019 Feb 11. doi: 10.1111/jth.14405. [Epub ahead of print]

PMID:
30740865
2.

Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors.

Dahlbäck B, Guo LJ, Livaja-Koshiar R, Tran S.

Res Pract Thromb Haemost. 2017 Dec 20;2(1):114-124. doi: 10.1002/rth2.12057. eCollection 2018 Jan.

3.

Treating hemophilia by targeting protein S?

Dahlbäck B.

Blood. 2018 Mar 22;131(12):1271-1272. doi: 10.1182/blood-2018-01-828152. No abstract available.

PMID:
29567756
4.

Lean ApoM-/- Mice with Hyperactive Brown Adipose Tissue.

Dahlbäck B.

Trends Endocrinol Metab. 2018 May;29(5):283-284. doi: 10.1016/j.tem.2018.02.011. Epub 2018 Mar 13.

PMID:
29548806
5.

High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.

Brinck JW, Thomas A, Brulhart-Meynet MC, Lauer E, Frej C, Dahlbäck B, Stenvinkel P, James RW, Frias MA.

Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12866. Epub 2017 Dec 14.

PMID:
29178180
6.

Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism.

Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Elf J, Svensson PJ, Strandberg K, Sundquist J, Memon AA.

Clin Appl Thromb Hemost. 2018 Apr;24(3):416-422. doi: 10.1177/1076029617730639. Epub 2017 Sep 15.

PMID:
28914078
7.

Vitamin K-Dependent Protein S: Beyond the Protein C Pathway.

Dahlbäck B.

Semin Thromb Hemost. 2018 Mar;44(2):176-184. doi: 10.1055/s-0037-1604092. Epub 2017 Sep 13. Review.

PMID:
28905350
8.

Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.

Dahlbäck B.

J Thromb Haemost. 2017 Jul;15(7):1241-1250. doi: 10.1111/jth.13665. Review.

PMID:
28671348
9.

The nanoparticle protein corona formed in human blood or human blood fractions.

Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlbäck B, Linse S, Cedervall T.

PLoS One. 2017 Apr 17;12(4):e0175871. doi: 10.1371/journal.pone.0175871. eCollection 2017.

10.

Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma.

Grabiec AM, Denny N, Doherty JA, Happonen KE, Hankinson J, Connolly E, Fife ME, Fujimori T, Fujino N, Goenka A, Holden S, Tavernier G, Shah R, Cook PC, MacDonald AS, Niven RM, Dahlbäck B, Fowler SJ, Simpson A, Hussell T.

J Allergy Clin Immunol. 2017 Oct;140(4):1144-1146.e4. doi: 10.1016/j.jaci.2017.03.024. Epub 2017 Apr 12. No abstract available.

11.

A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.

Frej C, Mendez AJ, Ruiz M, Castillo M, Hughes TA, Dahlbäck B, Goldberg RB.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1194-1205. doi: 10.1161/ATVBAHA.117.309275. Epub 2017 Apr 6.

PMID:
28385702
12.

Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages.

Gustafsson A, Fritz HKM, Dahlbäck B.

Exp Cell Res. 2017 Jun 1;355(1):47-56. doi: 10.1016/j.yexcr.2017.03.040. Epub 2017 Mar 19.

PMID:
28327411
13.

Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier.

Kober AC, Manavalan APC, Tam-Amersdorfer C, Holmér A, Saeed A, Fanaee-Danesh E, Zandl M, Albrecher NM, Björkhem I, Kostner GM, Dahlbäck B, Panzenboeck U.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Jun;1862(6):573-588. doi: 10.1016/j.bbalip.2017.03.003. Epub 2017 Mar 14.

PMID:
28315462
14.

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.

Ruiz M, Okada H, Dahlbäck B.

Lipids Health Dis. 2017 Feb 8;16(1):36. doi: 10.1186/s12944-017-0429-2.

15.

High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.

Ruiz M, Frej C, Holmér A, Guo LJ, Tran S, Dahlbäck B.

Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):118-129. doi: 10.1161/ATVBAHA.116.308435. Epub 2016 Nov 22.

PMID:
27879252
16.

Epidemiology of Familial Aggregation of Venous Thromboembolism.

Zöller B, Li X, Ohlsson H, Ji J, Memon AA, Svensson PJ, Palmér K, Dahlbäck B, Sundquist J, Sundquist K.

Semin Thromb Hemost. 2016 Nov;42(8):821-832. Epub 2016 Oct 20. Review.

PMID:
27764883
17.

Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.

Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Svensson PJ, Sundquist J, Memon AA.

Thromb Haemost. 2016 Aug 30;116(3):432-41. doi: 10.1160/TH16-03-0178. Epub 2016 Jun 9.

PMID:
27277397
18.

Familial hypercholesterolaemia: cholesterol efflux and coronary disease.

Versmissen J, Vongpromek R, Yahya R, van der Net JB, van Vark-van der Zee L, Blommesteijn-Touw J, Wattimena D, Rietveld T, Pullinger CR, Christoffersen C, Dahlbäck B, Kane JP, Mulder M, Sijbrands EJ.

Eur J Clin Invest. 2016 Jul;46(7):643-50. doi: 10.1111/eci.12643. Epub 2016 Jun 20.

19.

Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.

Dahlbäck B.

Int J Lab Hematol. 2016 May;38 Suppl 1:4-11. doi: 10.1111/ijlh.12508. Epub 2016 May 9. Review.

PMID:
27161771
20.

The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles.

Happonen KE, Tran S, Mörgelin M, Prince R, Calzavarini S, Angelillo-Scherrer A, Dahlbäck B.

J Biol Chem. 2016 May 13;291(20):10586-601. doi: 10.1074/jbc.M115.699058. Epub 2016 Mar 22.

21.

Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.

Frej C, Linder A, Happonen KE, Taylor FB, Lupu F, Dahlbäck B.

J Cell Mol Med. 2016 Jun;20(6):1170-81. doi: 10.1111/jcmm.12831. Epub 2016 Mar 17.

22.

Gas6 fueling tumor-mediated thrombosis.

Happonen KE, Dahlbäck B.

Blood. 2016 Feb 11;127(6):672-3. doi: 10.1182/blood-2015-12-683474. No abstract available.

23.

Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.

Svarrer EM, Andersen HØ, Helvind M, Slagman MC, Navis G, Dullaart RP, Dahlbäck B, Nielsen LB.

Biomark Med. 2016;10(1):81-93. doi: 10.2217/bmm.15.105. Epub 2015 Dec 7.

24.

Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.

Frej C, Andersson A, Larsson B, Guo LJ, Norström E, Happonen KE, Dahlbäck B.

Anal Bioanal Chem. 2015 Nov;407(28):8533-42. doi: 10.1007/s00216-015-9008-4. Epub 2015 Sep 16.

25.

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.

Fritz HK, Gustafsson A, Ljungberg B, Ceder Y, Axelson H, Dahlbäck B.

PLoS One. 2015 Aug 19;10(8):e0135991. doi: 10.1371/journal.pone.0135991. eCollection 2015.

26.

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.

Galvani S, Sanson M, Blaho VA, Swendeman SL, Obinata H, Conger H, Dahlbäck B, Kono M, Proia RL, Smith JD, Hla T.

Sci Signal. 2015 Aug 11;8(389):ra79. doi: 10.1126/scisignal.aaa2581. Erratum in: Sci Signal. 2015 Oct 27;8(400):er8. Obinata, Hideru [added].

27.

Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

Somajo S, Ahnström J, Fernandez-Recio J, Gierula M, Villoutreix BO, Dahlbäck B.

Thromb Haemost. 2015 May;113(5):976-87. doi: 10.1160/TH14-09-0803. Epub 2015 Feb 26.

PMID:
25716664
28.

Protein unfolding allows use of commercial antibodies in an apolipoprotein M sandwich ELISA.

Bosteen MH, Dahlbäck B, Nielsen LB, Christoffersen C.

J Lipid Res. 2015 Mar;56(3):754-9. doi: 10.1194/jlr.D055947. Epub 2015 Jan 5.

29.

Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Koshiar RL, Somajo S, Norström E, Dahlbäck B.

PLoS One. 2014 Aug 19;9(8):e104200. doi: 10.1371/journal.pone.0104200. eCollection 2014.

30.

Size-dependent effects of nanoparticles on enzymes in the blood coagulation cascade.

Sanfins E, Augustsson C, Dahlbäck B, Linse S, Cedervall T.

Nano Lett. 2014 Aug 13;14(8):4736-44. doi: 10.1021/nl501863u. Epub 2014 Jul 21.

PMID:
25025946
31.

The association between apolipoprotein M and insulin resistance varies with country of birth.

Memon AA, Bennet L, Zöller B, Wang X, Palmér K, Dahlbäck B, Sundquist J, Sundquist K.

Nutr Metab Cardiovasc Dis. 2014 Nov;24(11):1174-80. doi: 10.1016/j.numecd.2014.05.007. Epub 2014 May 29.

PMID:
24984825
32.

Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.

Somajo S, Koshiar RL, Norström E, Dahlbäck B.

Thromb Res. 2014 Jul;134(1):144-52. doi: 10.1016/j.thromres.2014.04.031. Epub 2014 May 2.

PMID:
24835672
33.

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

Fritz HKM, Lindgren D, Ljungberg B, Axelson H, Dahlbäck B.

Eur J Cancer. 2014 Jul;50(10):1758-1765. doi: 10.1016/j.ejca.2014.03.281. Epub 2014 Apr 30.

PMID:
24793999
34.

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Reglińska-Matveyev N, Andersson HM, Rezende SM, Dahlbäck B, Crawley JT, Lane DA, Ahnström J.

Blood. 2014 Jun 19;123(25):3979-87. doi: 10.1182/blood-2014-01-551812. Epub 2014 Apr 16.

35.

Targeting exosites of activated protein C as therapeutic possibility?

Dahlbäck B.

Thromb Res. 2014 Jun;133(6):963-4. doi: 10.1016/j.thromres.2014.02.013. Epub 2014 Feb 22. No abstract available.

PMID:
24612601
36.

Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.

Memon AA, Sundquist J, Zöller B, Wang X, Dahlbäck B, Svensson PJ, Sundquist K.

Thromb Res. 2014 Mar;133(3):322-6. doi: 10.1016/j.thromres.2013.12.006. Epub 2013 Dec 10.

PMID:
24359967
37.

Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.

Vincent LM, Tran S, Livaja R, Bensend TA, Milewicz DM, Dahlbäck B.

J Clin Invest. 2013 Sep;123(9):3777-87. doi: 10.1172/JCI69091. Epub 2013 Aug 27.

38.

Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation.

Calzavarini S, Villoutreix BO, Lunghi B, Livaja R, Bernardi F, Dahlbäck B.

Thromb Haemost. 2013 Jul;110(1):31-8. doi: 10.1160/TH12-10-0780. Epub 2013 Apr 25.

PMID:
23616041
39.

The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.

Christoffersen C, Benn M, Christensen PM, Gordts PL, Roebroek AJ, Frikke-Schmidt R, Tybjaerg-Hansen A, Dahlbäck B, Nielsen LB.

J Lipid Res. 2012 Oct;53(10):2198-204. doi: 10.1194/jlr.P023697. Epub 2012 Jul 23.

40.

Small and large PROS1 deletions but no other types of rearrangements detected in patients with protein S deficiency.

Lind-Halldén C, Dahlen A, Hillarp A, Zöller B, Dahlbäck B, Halldén C.

Thromb Haemost. 2012 Jul;108(1):94-100. doi: 10.1160/TH12-01-0040. Epub 2012 May 25.

PMID:
22627709
41.

Biocompatibility of mannan nanogel--safe interaction with plasma proteins.

Ferreira SA, Oslakovic C, Cukalevski R, Frohm B, Dahlbäck B, Linse S, Gama FM, Cedervall T.

Biochim Biophys Acta. 2012 Jul;1820(7):1043-51. doi: 10.1016/j.bbagen.2012.04.015. Epub 2012 Apr 24.

PMID:
22554917
42.

Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.

Kumaraswamy SB, Linder A, Åkesson P, Dahlbäck B.

Crit Care. 2012 Dec 12;16(2):R60. doi: 10.1186/cc11305.

43.

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.

Elsøe S, Ahnström J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, Binder CJ, Björkbacka H, Dahlbäck B, Nielsen LB.

Atherosclerosis. 2012 Mar;221(1):91-7. doi: 10.1016/j.atherosclerosis.2011.11.031. Epub 2011 Nov 27.

PMID:
22204862
44.

Polystyrene nanoparticles affecting blood coagulation.

Oslakovic C, Cedervall T, Linse S, Dahlbäck B.

Nanomedicine. 2012 Aug;8(6):981-6. doi: 10.1016/j.nano.2011.12.001. Epub 2011 Dec 23.

PMID:
22197724
45.

Coagulation and inflammation--close allies in health and disease.

Dahlbäck B.

Semin Immunopathol. 2012 Jan;34(1):1-3. doi: 10.1007/s00281-011-0298-0. Epub 2011 Nov 5.

PMID:
22051939
46.

Structural changes in apolipoproteins bound to nanoparticles.

Cukalevski R, Lundqvist M, Oslakovic C, Dahlbäck B, Linse S, Cedervall T.

Langmuir. 2011 Dec 6;27(23):14360-9. doi: 10.1021/la203290a. Epub 2011 Nov 2.

PMID:
21978381
47.

C4b-binding protein: a forgotten factor in thrombosis and hemostasis.

Dahlbäck B.

Semin Thromb Hemost. 2011 Jun;37(4):355-61. doi: 10.1055/s-0031-1276584. Epub 2011 Jul 30. Review.

PMID:
21805441
48.

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.

Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnström J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlbäck B.

Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9613-8. doi: 10.1073/pnas.1103187108. Epub 2011 May 23.

49.

Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue.

Ahnström J, Andersson HM, Canis K, Norstrøm E, Yu Y, Dahlbäck B, Panico M, Morris HR, Crawley JT, Lane DA.

Blood. 2011 Jun 16;117(24):6685-93. doi: 10.1182/blood-2010-11-317099. Epub 2011 Apr 20.

50.

Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.

Wu J, Ekman C, Jönsen A, Sturfelt G, Bengtsson AA, Gottsäter A, Lindblad B, Lindqvist E, Saxne T, Dahlbäck B.

Arthritis Res Ther. 2011 Apr 15;13(2):R62. doi: 10.1186/ar3316.

Supplemental Content

Loading ...
Support Center